Could a simple mineral ease migraines faster in the ER?

NCT ID NCT06904287

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether giving magnesium along with the standard migraine drug prochlorperazine reduces pain more than the drug alone. About 100 adults with migraines in the emergency department will receive either the combination or a placebo. Researchers will measure pain changes at 30, 45, and 60 minutes after treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

magnesium

What this could lead to

If it works, this could give emergency doctors a simple, safe way to relieve migraine pain more quickly.

What could go wrong

This is a small, early-phase trial with only 100 participants. The benefit may be small or not apply to all migraine types.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MIGRAINE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

migraine disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Advocate Christ Medical Center Emergency Department

    RECRUITING

    Oak Lawn, Illinois, 60453, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••